(CNS) |
| 0 (0%) 01-13 21:09 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 80.68 |
| Resistance 1: | 69.07 |
| Pivot price: | 65.09 |
| Support 1: | 62.47 |
| Support 2: | 58.39 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 3.190 |
| Book Value | 10.790 |
| PEG Ratio | 0.00 |
| Gross Profit | 5.180 |
| Profit Margin (%) | 29.73 |
| Operating Margin (%) | 34.51 |
| Return on Assets (ttm) | 15.3 |
| Return on Equity (ttm) | 31.1 |
Company news
Tue, 13 Jan 2026
LG CNS to Deploy Robots in Production Lines in Two Years - 조선일보
Tue, 13 Jan 2026
South Carolina lab pleads guilty in $6.8M kickback case; 1 in 4 dementia patients prescribed risky CNS drugs; FDA eases manufacturing rules for cell and gene therapies – Morning Medical Update - Medical Economics
Tue, 13 Jan 2026
LG CNS sees physical AI hitting factory floors within two years - The Korea Herald
Tue, 13 Jan 2026
Dyno Therapeutics Launches Dyno-yp2, a Top-Performing TfR1-Mediated AAV Capsid, to Further Diversify CNS Delivery Portfolio - BioSpace
Tue, 13 Jan 2026
Xinhepu Historical and Cultural Precinct Core Area Enhancement Project / Atelier cnS - ArchDaily
Mon, 12 Jan 2026
One in four older Americans with dementia is prescribed high-risk CNS meds, study finds - McKnight's Long-Term Care News
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
